Zobrazeno 1 - 10
of 23
pro vyhledávání: '"José H. Leborgne"'
Autor:
Felix Leborgne, José H. Leborgne, Bettys Ortega, René Curochquin, Julieta Mezzera, Mercedes Mullin
Publikováno v:
Revista Médica del Uruguay, Vol 24, Iss 1 (2008)
Introducción: se estudiaron los efectos de la dosis de radioterapia y del uso de hormonoterapia asociada en pacientes con cáncer de próstata, sobre la sobrevida libre de recaída bioquímica, la mortalidad causa específica y la mortalidad global.
Externí odkaz:
https://doaj.org/article/bb633f284dac43cc888b69947c730ce6
Autor:
Félix Leborgne, José H. Leborgne, Eduardo Zubizarreta, Bettys Ortega, José Leborgne Deus, Sergio Aguiar, René Curochquin, Julieta Mezzera, Mercedes Mullin, Francisco Leborgne, Jorge Beraza
Publikováno v:
Revista Médica del Uruguay, Vol 20, Iss 3 (2004)
Se analizaron 560 pacientes consecutivos con cáncer localizado de próstata tratados con radioterapia conformal tridimensional entre 1993 y 2001. La sobrevida global actuarial a los nueve años fue de 71%, y la sobrevida causa específica de 88%. La
Externí odkaz:
https://doaj.org/article/472a0c357510403a92faba9a73f35bee
Autor:
Sergio Aguiar, Bettys Ortega, María Luisa Terradas, Mauro Giordano, José H. Leborgne, Julieta Mezzera, Valentina Lestido
Publikováno v:
Revista Médica del Uruguay, Volume: 35, Issue: 4, Pages: 29-51, Published: 01 DEC 2019
Resumen: Introducción: el cáncer de canal anal representa aproximadamente un 2% a 3% de todas las neoplasias digestivas. Nigro describió el tratamiento conservador del cáncer de canal anal utilizando radioterapia y quimioterapia con 5-fluorouraci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e57ff32df7de8839afdb663c34e1b36
https://doi.org/10.29193/rmu.35.4.2
https://doi.org/10.29193/rmu.35.4.2
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:1200-1207
Purpose Now that the follow-up time has exceeded 5 years, an estimate of the α/β ratio can be presented. The additional late outcomes in patients treated with three-dimensional conformal external beam radiotherapy for localized prostate cancer usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fc92ee6b9d655cb32a3e9de59cff97
https://doi.org/10.1016/j.ijrobp.2010.12.040
https://doi.org/10.1016/j.ijrobp.2010.12.040
Publikováno v:
Cancer. 91:2353-2360
BACKGROUND The authors undertook a retrospective study on local tumor control, survival, and complications of conventional irradiation compared with accelerated hyperfractionated irradiation in women with selected head and neck tumor sites. METHODS O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fafc0102b6aabd406c89e50dd9bb03c9
https://doi.org/10.1002/1097-0142(20010615)91:12<2353::aid-cncr1268>3.0.co
https://doi.org/10.1002/1097-0142(20010615)91:12<2353::aid-cncr1268>3.0.co
Publikováno v:
Head & Neck. 23:661-668
Background and Purpose Optimal treatment duration of altered fractionation schedules in head and neck cancer is still undefined. A retrospective study on local tumor control, survival, and complications of accelerated hyperfractionated irradiation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0870270d77a3de72746efaa67ac05bb
https://doi.org/10.1002/hed.1093
https://doi.org/10.1002/hed.1093
Autor:
José Leborgne Deus, Jack F. Fowler, José H. Leborgne, Eduardo Zubizarreta, Julieta Mezzera, Felix Leborgne, Bettys Ortega
Publikováno v:
International Journal of Cancer. 90:80-91
SUMMARY A retrospective study on local tumor control, survival, and complications of conventional irradiation vs. accelerated hyperfractionated irradiation in patients with selected head and neck cancer sites was undertaken. A total of 1,007 consecut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d16f3ac50cf35d12952ef89c0a99d39f
https://doi.org/10.1002/(sici)1097-0215(20000420)90:2<80::aid-ijc4>3.0.co
https://doi.org/10.1002/(sici)1097-0215(20000420)90:2<80::aid-ijc4>3.0.co
Publikováno v:
Radiotherapy and Oncology. 47:145-148
Patients with head and neck cancer were randomized in a double-blind manner to receive 40 mg/day prednisone (n = 32) or placebo (n = 34). The prescribed daily tumour dose was 1.6 Gy twice daily with an interfraction interval of > or =6 h. Treatment i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a3f830918eecc40d053baf5ae46b39
https://doi.org/10.1016/s0167-8140(97)00174-6
https://doi.org/10.1016/s0167-8140(97)00174-6
Publikováno v:
Radiation Oncology Investigations. 5:289-299
The amount of dose reduction on changing from low dose rate (LDR) brachytherapy to medium dose rate (MDR) or high dose rate (HDR) afterloading has been the subject of much debate. The magnitude of reduction depends, together with other possible facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f65b1327526a313aac58560010b1d25
https://doi.org/10.1002/(sici)1520-6823(1997)5:6<289::aid-roi5>3.0.co
https://doi.org/10.1002/(sici)1520-6823(1997)5:6<289::aid-roi5>3.0.co
Publikováno v:
Revista Médica del Uruguay, Vol 22, Iss 4 (2006)
Introducción: se estudiaron los resultados de la irradiación posprostatectomía radical por cáncer de próstata. Material y método: se analizaron 131 pacientes consecutivos tratados entre 1994 y 2004. Treinta y ocho pacientes fueron irradiados en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::67789adbc5be28de005b3b22a73991fd
http://revista.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/662
http://revista.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/662